Healthcare Press

FDA approves groundbreaking treatment for advanced melanoma

  • 📰 NBCNewsHealth
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 51%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Erika Edwards is a health and medical news writer and reporter for NBC News and 'TODAY.'

The Food and Drug Administration on Friday approved a new cancer therapy that could one day transform the way a majority of aggressive and advanced tumors are treated. The treatment, called Amtagvi, from Iovance Biotherapeutics, is for metastatic melanoma patients who have already tried and failed other drugs. It’s known as TIL therapy and involves boosting the number of immune cells inside tumors, harnessing their power to fight the cancer.

Steven Rosenberg, chief of the surgery branch at the National Cancer Institute. “They’re a small price to pay for a growing cancer that would otherwise be lethal.” Overall, Dahut said the approval of TIL therapy is “meaningful.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 707. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

CDC hasn't changed Covid guidelines yet: Here’s what you need to knowErika Edwards is a health and medical news writer and reporter for NBC News and 'TODAY.'
Source: NBCNewsHealth - 🏆 707. / 51 Read more »

CDC may recommend some people get a new Covid booster this springErika Edwards is a health and medical news writer and reporter for NBC News and 'TODAY.'
Source: NBCNewsHealth - 🏆 707. / 51 Read more »